Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$26.68 -0.71 (-2.59%)
At close: Sep 29, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Operating Expenses (2013 - 2026)

Updated

Amphastar Pharmaceuticals (AMPH) recorded Operating Expenses of $53.74 million in Q2 2026, up 21.3% from $44.31 million a year earlier but down 5.2% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Operating Expenses (2013 - 2026) Analysis & Trends

On a TTM basis, Amphastar Pharmaceuticals' Operating Expenses came in at $233.82 million as of Jun 30, 2026, up 30.9% year-over-year; for FY2025, it came in at $215.65 million, up 28.0% from FY2024.

  • Annual Operating Expenses has increased for four straight years, with a five-year compound annual growth rate of 10.3% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $168.44 million in FY2024 (+9.3%), $154.13 million in FY2023 (+9.0%), $141.36 million in FY2022 (+8.9%) and $129.85 million in FY2021 (-1.9%).
  • Quarterly Operating Expenses has ranged from $26.41 million in Q3 2021 to $73.33 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Operating Expenses has increased for six consecutive quarters, with growth averaging 21.6% over the last eight quarters.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 63.3% in Q3 2025, against a decline of 19.9% in Q3 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $56.69 million (Q1 2026), $50.06 million (Q4 2025) and $73.33 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Amphastar Pharmaceuticals 1.16 Bn 23.86 Mn 93.47 Mn 53.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 53.74 Mn
Mar 31, 2026 56.69 Mn
Dec 31, 2025 50.06 Mn
Sep 30, 2025 73.33 Mn
Jun 30, 2025 44.31 Mn
Mar 31, 2025 47.96 Mn
Dec 31, 2024 41.50 Mn
Sep 30, 2024 44.89 Mn
Jun 30, 2024 39.95 Mn
Mar 31, 2024 42.09 Mn
Dec 31, 2023 42.16 Mn
Sep 30, 2023 35.73 Mn
Jun 30, 2023 35.84 Mn
Mar 31, 2023 40.41 Mn
Dec 31, 2022 33.34 Mn
Sep 30, 2022 35.28 Mn
Jun 30, 2022 38.53 Mn
Mar 31, 2022 34.21 Mn
Dec 31, 2021 31.98 Mn
Sep 30, 2021 26.41 Mn
API Access

Amphastar Pharmaceuticals Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=AMPH&period=max&api_key=YOUR_API_KEY